Novavax sells Czech facility to Novo Nordisk for 200 million
NVAX Stock | USD 8.40 0.13 1.52% |
Slightly above 62% of Novavax's investor base is looking to short. The analysis of the overall investor sentiment regarding Novavax suggests that many traders are alarmed. Novavax's investing sentiment can be driven by a variety of factors including economic data, Novavax's earnings reports, geopolitical events, and overall market trends.
Novavax |
Novavax sells Czech facility to Novo Nordisk for 200 million
Read at investing.com
Novavax Current Investor Sentiment
Panic Vs Confidence
38
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Novavax's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Novavax.
News SentimentBullish | Hype SentimentBearish | Insider SentimentDisposing |
Novavax Maximum Pain Price Across April 17th 2025 Option Contracts
Novavax's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Novavax close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Novavax's options.
Novavax Fundamental Analysis
We analyze Novavax's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Novavax using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Novavax based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Owned By Institutions
Shares Owned By Institutions Comparative Analysis
Novavax is currently under evaluation in shares owned by institutions category among its peers. Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
Novavax Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Novavax stock to make a market-neutral strategy. Peer analysis of Novavax could also be used in its relative valuation, which is a method of valuing Novavax by comparing valuation metrics with similar companies.
Peers
Novavax Related Equities
INO | Inovio Pharmaceuticals | 8.90 | ||||
VXRT | Vaxart | 1.37 | ||||
MRNA | Moderna | 0.89 | ||||
AZN | AstraZeneca PLC | 0.46 | ||||
BNTX | BioNTech | 0.74 |
Additional Tools for Novavax Stock Analysis
When running Novavax's price analysis, check to measure Novavax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novavax is operating at the current time. Most of Novavax's value examination focuses on studying past and present price action to predict the probability of Novavax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novavax's price. Additionally, you may evaluate how the addition of Novavax to your portfolios can decrease your overall portfolio volatility.